LogoHeader2

LogoHeadermobilna

Публикације 2017-2022. године

  1. Vukoja M, Kopitovic I, Lazic Z, Milenkovic B, Stankovic I, Zvezdin B, Dudvarski Ilic A, Cekerevac I, Vukcevic M, Zugic V, Hromis S. Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement. International Journal of Chronic Obstructive Pulmonary Disease 2019.

  2. Bogdan M, Slavic D, Babovic S, Zvezdin B, Kolarov V, Kljajić V.Olfactory perception and different decongestive response of the nasal mucosa during menstrual cycle. American Journal of Rhinology & Allergy 2021.

  3. Lazic Z, Stankovic I, Milenkovic B, Zvezdin B, Hromis S, Jankovic S, Cupurdija V. Characteristics of COPD Phenotypes in Serbia. International Journal of Chronic Obstructive Pulmonary Disease 2021.

  4. Preveden A, Todić M, Drljević Todić V, Preveden M, Zdravković R, Zvezdin B. Use of beta blockers in patients with asthma and cchronic obstructive pulmonary diseases. Med Pregl 2021.

  5. Ćupurdija V, Milenković B, Žugić V, Stanković I, Zvezdin B, Hromiš S, Lazić Z. Registries of Patients with Chronic Obstructive Pulmonary Diseases – Why Are They Important? Medicus 2021.

  6. Milosevic M. Treasure T. A well-balanced randomized controlled trial in 93 patients is more trustworthy than attempted propensity matching in 38 patients: comments on Schlachtenberger et al.European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 2022.

  7. Cavic M, Kovacevic T, Zaric B, Dejan Stojiljkovic D, Natasa Jovanovic Korda N, Milan Rancic M, Radmila Jankovic R, Davorin Radosavljevic D , Goran Stojanovic G, Jelena Spasic J. Lung Cancer in Serbia. JTO. 2022..

  8. Alvarez-Romero C, Martínez-García A, Ternero-Vega J, Díaz-Jiménez P, Jiménez-De-Juan C, Nieto-Martín Md, Román-Villarán E, Kovacevic T, Bokan D, Hromis S, Djekic Malbasa J, Beslac S, Zaric B, Gencturk M, Sinaci A, Ollero-Baturone M, Parra-Calderón C. Predicting 30-days Readmission Risk for COPD Patients Care through a Federated Machine Learning Architecture on FAIR Data: Development and Validation Study. JMIR Medical Informatics. 2022.

  9. Bursac D, Zaric B, Bokan D, Kovacevic T, Stojsic V. Svetlana Petkov V, Mitrovic V, Stojanovic G. Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients. Vojnosanit. Pregl. 2022.

  10. Alvarez-Romero C, Martínez-García A, Sinaci A, Gencturk M, E, Hernandez-Perez T, Liperoti R, Angioletti C, Lobe M, Ganapthy N, Desderno T, Almada M, Costa E, Chronaki C, Cangioli G, Cornet R, Pablador-Plou B, Carmona-Pirez C, Gimeno-Miguel A, Poncel-Falco A, Prados-Torres A, Kovacevic T, Zaric B, Bokan D, Hromis S, Djekic Malbasa J, Rapalo Fernandez C, Velasquez Fernandez T, Rochat J, Gaudet-Blavignac C, Lovis C, Weber P, Quintero M, Perez-Perez MM, Ashley K, Horton L, Parra-Calderón C. FAIR4Health: Findable, Accessible, Interoperable and Reusable data to foster Health Research. Open Research Europe 2022.

  11. Bokan D. Zaric B. Kovacevic T. Djekic-Malbasa J. Andrijevic I. Lung cancer epidemiology and survival outcomes in Vojvodina. ANNALS OF ONCOLOGY. 2022.

  12. Zarogoulidis P, Petridis D, Huang H, Bai C, Hohenforst-Schmidt W, Freitag L, Baka S, Drougas D, Vagionas A, Tsakiridis K, Turner JF, Hatzibougias D, Boukovinas I, Zaric B, Kovacevic T, Ioannidis A, Courcoutsakis N, Matthaios D, Sardeli C. Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study. EXPERT REVIEW OF RESPIRATORY MEDICINE. 2021.

  13. Zarogoulidis P, Christakidis V, Petridis P, Sapalidis S, Kosmidis C, Vagionas A, Perdikouri EI, HohenforstSchmidt W, Huang H, Petanidis S, K, Baka S, Romanidis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T,Bursac D, Kukic B, Boukovinas I, Tolis C, Sardeli C. Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination. Expert Rev Respir Med. .

  14. Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, Vagionas A, Hohenforst-Schmidt W, Freitag L, Huang H, Bai C, Drougas D, Theofilatou V, Romanidis K, Perdikouri EI, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Perin B, Courcoutsakis N, Athanasiou E, D Hatzibougias, Drevelegas K, Boukovinas I, Kosmidou M, Kosmidis C. Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA. J Cancer. 2020; 11(21): 6454–6459.

  15. Shi D, Li F, Wang K, Kong C, Huang H, Li Q, Jin F, Hu C, Wang C, Shi H, Hu Z, Dong Y, Ning Y, Tsakiridis K,Sapalidis K, Kosmidis C, Vagionas A, Hohenforst-Schmidt W, Freitag L, Turner JF, Drevelegas K, Perdikouri EI, Kovacevic T, Sarcev T, Zaric B, Petanidis S, Baka S, Boukovinas I, Kakolyris S, Zarogoulidis P, Bai C. The development of bronchoscopy in China: a national cross-sectional study. J Cancer. 2020; 11(19): 5547–5555

  16. Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, Vagionas A, Hohenforst-Schmidt W, Freitag L, Huang H, Bai C, Drougas D, Theofilatou V, Romanidis K, Perdikouri EI, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Perin B, Courcoutsakis N, Athanasiou E, D Hatzibougias, Drevelegas K, Boukovinas I, Kosmidou M, Kosmidis C.Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G. JOURNAL OF CANCER. 2021.

  17. Huang H, Li Q, Jin F, Hu C, Wang C, Shi H, Hu Z, Dong Y, Ning Y, Tsakiridis K,Sapalidis K, Kosmidis C, Vagionas A, Hohenforst-Schmidt W, Freitag L, Turner JF, Drevelegas K, Perdikouri EI, Kovacevic T, Sarcev T, Zaric B, Petanidis S, Baka S, Boukovinas I, Kakolyris S, Zarogoulidis PThyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons. EXPERT REVIEW OF MEDICAL DEVICES. 2021.

  18. Kovacevic T, Zaric B, Bokan D, Sazdanic Velikic D,Stojanov O. Nutritional status and psychiatric disorders among elderly lung cancer patients: special attention for better disease management. Support Care Cancer .2019.

  19. Kovacevic T, Zaric B, Bokan D. Impact of Depression, Anxiety and Malnutrition on Survival of Patients with NSCLC: Highlighting the Need for Early Assessment. Palliative medicine2019.

  20. Kolarov V, Kotur-Stevuljević J, Ilić M, Bogdan M, Tušek B, Agić A, Dugajlić M, Tot Vereš K, Stević-Kutlešić S, Zvezdin B. Factorial analysis of N-acetilcysteine and propolis treatment effects on symptoms, life quality and exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD): a randomized, duble-blind, placebo -controlled trial. European Review for Medical and Pharmacological Sciences 2022;26:3192-9.

  21. Tegeltija D, Lovrenski A, Vasiljević T, Samardžija G, Kuhajda I. Exogenous lipoid pneumonia mimicking multifocal subpleural tumors. Srp Arh Celok Lek. 2019.

  22. Lovrenski A, Ilić A, Kuhajda I,Tegeltija D, Lovrenski J. Intrapulmonary solitary fibrous tumor. Srp Arh Celok Lek. 2019.

  23. Lovrenski A, Vasilijević M, Panjković M,Tegeltija D, Vučković D, Baroš I, Lovrenski J. Sclerosing Pneumocytoma: A Ten-Year Experience at a Western Balkan University Hospital. Medicina 2019.

  24. Tegeltija D, Lovrenski A, Vasiljević A, Andrejić-Višnjić B. Adequacy of biopsy samples for EGFR molecular testing in lung adenocarcinoma. Vojnosanit Pregl. 2019.

  25. Lalić N, Tegeltija D, Kuhajda I, Tomić S, Lalić I. Metastatic atypical lung carcinoid treated with combined therapies. Srp Arh Celok Lek. .

  26. Džambas J, Aleksić I, Škuletić V, Cerović S, Tegeltija D. Correlation between cytological and histopathological diagnosis of non-small cell lung cancer and accuracy of cytology in diagnosis of lung cancer. Vojnosanit Pregl. In press. DOI: 10.2298/VSP200618117D.(M23)

  27. Tegeltija D, Lovrenski A, Vasiljević T, Maksimović S. Association between epidermal growth factor receptor mutation status, clinicopathological characteristics and TTF-1 expressionSrpArhCelokLek. 2021 Mar-Apr;149(3-4):174-178(M23)

  28. Sekerus V, Stojanovic G, Bursac D, Tegeltija D, Stolic M, Andrijevic I. Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790 M mutation testing .Clinica chimica astma 2019.

  29. Pupavac U, Tegeltija D, Lovrenski A, Sekeruš V, Maksimović S, Bijelović M, Oluški D.Kliničko-patološkekarakteristikemalignogpleuralnogmezotelioma – našepetogodišnjeiskustvo. MD-Medical Data 2019.

  30. Lovrenski A, KašikovićLečić S, Dragišić D, NovkovićOstojić S, Tegeltija D. Istovremenapojavasarkoidozei adenocarcinoma pluća-prikazslučaja. Respiratio. 2019.

  31. Lovrenski A, Tegeltija D, Pena Karan S, Maksimović S, KašikovićLeečić S, Kuhajda I. Biopsijapluća u dijagnoziintersticijalnihplućnihoboljenja. Respiratio. 2019.

  32. Maksimović S, Bijelović M, Tegeltija D,Lovrenski A, Ergelašev I, Simetić V. Švanominterkostalnihnerava. Respiratio. 2019.

  33. TegeltijaD,Lovrenski A, Vasiljević T, Sekeruš V, Maksimović S, Kuhajda I, Bijelović M, Ivanić M, Ilić M. Da li je histološkagrađa adenocarcinoma pluća u dijagnostičkimiterapijskimuzorcimaidentična? Respiratio. 2019.

  34. Valipour A, Aisanov Z, Avdeev S, Koblizek V, Kocan I, Kopitovic I, Lupkovics G, Man M, Bukovskis M, Tudoric N, Vukoja M, Naumnik W, Yanev N. Recommendations for COPD management in Central and Eastern Europe. Expert Rev Respir Med. 2022.

  35. Vukoja M, Dong Y, Adhikari NKJ, Schultz MJ, Arabi YM, Martin-Loeches I, Hache M, Gavrilovic S, Kashyap R, Gajic O; Checklist for Early Recognition and Treatment of Acute Illness and Injury (CERTAIN) Investigators of the SCCM Discovery Network. Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources. Crit Care Med. 2021.

  36. Samardžija G, Popović M, Lovrenski A, Miljković D, Tegeltija D. Papilaryfibroelastoma of the heart – 10 years experience from Institute of Cardiovascular Diseases, SremskaKamenica. MD-Medical Data 2019.

  37. Vrekić Ž, Lovrenski A, Tegeltija D, NovkovićOstojić S, Krajnović B, Považan A. MD-Medical Data 2019.

  38. NovkovićOstojić S, Vujasinović G, SazdanićVelikić D, Tegeltija D, PrvulovićBunović N, Mihailović J, Sečen N. Gigantska bula I karcinom pluća. MD-Medical Data 2020.Tegeltija D, Krajnović B, Sekeruš V, Stojanović G, Zarić B, Lovrenski A, MiljkovićD,Vasiljevićć T, Maksimović S. NAŠA PRVA ISKUSTVA U EVALUACIJI PD-L1 EKSPRESIJE. MD-Medical Data 2021;13(2): 059-064 .(M52)

  39. Lovrenski A, Tegeltija D, Miljković D, Sekeruš V, Stojšić V, Zarić B. Imunohistohemijsko testiranje ALK rearanžmana u bolesnika sa uznapredovalim nesitnoćelijskim karcinomom pluća. In: 6 Kongres respiratorne medicine Srbije sa međunarodnim učešćem; 2019 Nov 15-17; Kopaonik, Srbija. Medical Data 2019; 11 (Suppl):118-9. (M64).

  40. Maksimović S, Kuhajda I, Đurić D, Bijelović M, Milšević M, Anđelković D, Ergelašev I, Petrović S, Tegeltija D,Lovrenski A. Sklerozirajućipneumocitom: prikazslučajaipregled literature. In: 6 Kongresrespiratorne medicine Srbijesameđunarodnimučešćem; 2019 Nov 15-17; Kopaonik, Srbija. Medical Data 2019; 11 (Suppl):119-20.(M64)

  41. Tegeltija D,Lovrenski A, Sekeruš V, Maksimović S, Kuhajda I. Popović M. EGFR mutacije – naaša iskustva. In: 6 Kongresrespiratorne medicine Srbijesameđunarodnimučešćem; 2019 Nov 15-17; Kopaonik, Srbija. Medical Data 2019; 11 (Suppl):144-5. (M64)

  42. N.Savić, Z. Marković, Ž. Eri, B. Koledin, D. Đekić, Javorac J,Primary pulmonary botriomycosis-case report, Medical data 2019,PP29.

  43. J. Javorac, Z. Pavlović-Popović, D.Dragišić, D. Vukosav, N. Savić, D.Đekić, D. Živanović, Lung manifestations of Langer-Hans cell histiocytosis:cese report,Medical data 2019, PP13.

  44. M. Ilic, K. Tot Veres, N. Savic, A. Milenkovic, I. Kopitovic, What pneumonococcal vaccine means on chronic obrstructive pulmonary disease among elderly patients and comorbidity, ERS 2020, online congress.

  45. M. Ilic, I. Kopitovic, J. Javorac, D. Kukavica, N. Savic, D. Vukosav, N. Lalic, Will There Be a Permanent Problem with Tuberculosis in Future Due to the Second Category of Patients in Serbia. Katrd International Conference 2021, Nov 11-12, Seoul, Korea, p348

  46. J. Javorac, D. Zivanovic, M. Ilic, I. Kopitovic, A. Milenkovic, N. Savic, Tracheobronchopathia Osteochondroplastica: A Study of 22 Patients from Serbia. Katrd 2021, International Conference 2021, Nov 11-12, Seoul, Korea. p551

  47. M. Ilic, N. Savic, N. Lalic, K. Tot Veres, J. Javorac, I. Kopitovic, How the Covid19 pandemic changed attitude versus seasonal flu vaccinationamong COPD patients in Serbia, ERS 2021, online congress.

  48. Milenković, M. Ilić, J. Javorac, N. Savić, N.Lalić, Limfangiolejomiomatoza i langerhanshistiocitoza – dva prikaza bolesnika iz naše prakse, Srpski Arhiv 2022.

  49. Boskovic Tatjana V, Secen Nevena M, Vitorovic Sonja, Sevo Milica, Culibrk Tamara, Bokan Darijo, Can Prophylactic Cranial Irradiation Reduce Neurological Symptoms in Patients with Small Cell Lung Cancer? Journal of thoracic oncology 2019.

  50. Bojovic Marko,Lalic Nensi,Boskovic Tatjana V,Ilic Miroslav,Ivanov Olivera,Licina Jelena T,Nikolin Borislava,Kalember Sandro , High-dose-rate endobronchial brachytherapy in the management of advanced lung cancer-comparison according to the presence of lung atelectasis , Srpski arhiv za celokupno lekarstvo 2021.

  51. Miroslav Ilić, Ivan Kopitović, Aleksandra Vulin, Biljana Zvezdin, Sanja Hromiš, Violeta Kolarov, Danijela Kuhajda, Marija Vukoja. Frequency and effects of seasonal flu vaccines on exacerbations of chronic obstructive pulmonary disease in Serbia Vojnosanit Pregl 2021.

  52. Ilic M, Kopitovic I, Kuhajda D, Zvezdin B, Lalic N, Hromis S, Vulin A. The influence of pulmonary rehabilitation on the exacerbations of chronic obstructive pulmonary disease in Serbia. 345 Srp Arh Celok Lek. 2020

  53. Ana Milenković, Miroslav Ilić, Jovan Javorac, Nevena Savić, Nensi Lalić. Lymphangioleiomyomatosis and Langerhans cell histiocytosis – two case reports from our practice. Srp Arh Celok Lek 2022.

  54. Danijela Kuhajda, Ivan Kuhajda, Miroslav Ilić, Siniša Maksimović, Jelena Crnobrnja, Nensi Lalić, Marko Bojović. Risk factors as outcome predictors of pulmonary rehabilitation in patients with chronic obstructive pulmonary. Srp Arh Celok Lek. 2022 .

  55. Javorac, J.; Jevtic, M.; Živanovic, D.; Ilic, M.; Bijelovic, S.; Dragic, N. What Are the Effects of Meteorological Factors on Exacerbations of Chronic Obstructive Pulmonary Disease? Atmosphere 2021.

  56. Marko Bojović, Nensi Lalić, Tatjana Bošković, Miroslav Ilić, Olivera Ivanov, Jelena Ličina, Borislava Nikolin, Sandro Kalember. High-dose-rate endobronchial brachytherapy in the management of advanced lung cancer – comparison according to the presence of lung atelectasis. Srp Arh Celok Lek. 2021.

  57. Kopitovic I, Bokan A., Andrijevic I, Ilic M, Marinkovic S, Milicic D, Vukoja M: Frequency of COPD in health care workers who smoke J Bras Pneumol.2017.;

  58. M. Ilic, N. Savic, N. Lalic, K. Tot Veres, J. Javorac, I. Kopitovic, How the Covid19 pandemic changed attitude versus seasonal flu vaccinationamong COPD patients in Serbia, ERS 2021, online congress.

  59. Ilic M, Tot Veres K, Savic N, Milenkovic A, Kopitovic I. What pneumonococcal vaccine means on chronic obrstructive pulmonary disease among elderly patients and comorbidity. ERS 2020, online congress.

  60. Obradovic D., Joves B., Vujovic I., Vukoja M., Stefanovic S., Sovilj-Gmizic S. Is age-adjusted Modified Early Warning Score upon admission a relevant prognostic tool for final outcome? Srpski Arh Celok Lek 2020.

  61. Joves B., Obradovic D., Matijasevic J., Sovilj-Gmizic S., Vujovic I. Recognizing the high-risk patients with sepsis on time: MEWS, qSOFA or SIRS? Eur Respir J 2019.

  62. Lalić N, Tegeltija D, Kuhajda I, Tomić S, Lalić I. Metastatic atypical lung carcionoid treated with combined therapeutic modalities. Serbian Archives of Medicine 2019 Volume 147, Issue 11-12, Pages: 769-772.

  63. Tomić S, Malenković G, Lalić N, Bojović M, Tomić S. Effects of early rehabilitation treatment on the functional recovery and quality of life in patients three months after breast cancer surgery. Serbian Archives of Medicine 2020 Volume 148, Issue 5-6, Pages: 344-349.

  64. Goran Malenković, Sanja Tomić, Jasmina Boban, Nensi Lalić, Marko Bojović. Abdominal wall endometriosis: clinical presentation, imaging features and management of five cases. Serbian Archives of Medicine 2020 Volume 148, Issue 7-8, Pages: 484-488

  65. Miroslav Ilić, Ivan Kopitović, Danijela Kuhajda, Biljana Zvezdin, Nensi Lalić, Sanja Hromiš, Aleksandra Vulin The influence of pulmonary rehabilitation on the exacerbations of chronic obstructive pulmonary disease in Serbia. Serbian Archives of Medicine 2020 Volume 148, Issue 5-6, Pages: 344-349.

  66. Rastislava Krasnik1, Jelena Zvekić-Svorcan, Čila Demeši Drljan, Lidija Dimitrijević, Nensi Lalić, Aleksandra Mikov. The difference between the pain self-perceptions of children with cerebral palsy and those of their caregivers. Serbian Archives of Medicine 2021 Volume 149, Issue 1-2, Pages: 59-64.

  67. Kašiković Lečić S., Sazdanić Velikić D., Lalić N., Tegeltija D., Lovrenski A. From Bad to Worse: Idiopatic Pulmonary Fibrosis and Lung Cancer (IPF-LC). 10th Congress of the Croatian Thoracic Society (Abstract Book), 16-19 September 2020, Zagreb, Croatia.

  68. Marko Bojović, Nensi Lalić, Tatjana Bošković, Miroslav Ilić, Olivera Ivanov, Jelena Ličina, Borislava Nikolin, Sandro Kalember. High dose rate endobronchial brachytherapy in the management of advanced lung cancer – comparison according to the presence of lung atelectasis. Serbian Archives of Medicine 2022 Volume 148, Issue 1-2, Pages: 81-86

  69. Danijela Kuhajda, Ivan Kuhajda, Miroslav Ilić, Siniša Maksimović, Jelena Crnobrnja, Nensi Lalić, Marko Bojović. Risk factors as outcome predictors of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.Serbian Archives of Medicine 2022 Volume 150, Issue 1-2, Pages: 35-40.

  70. Rolim I, Makupson M, Lovrenski A, Farver C. Cathepsin K is Superior to HMB45 for the Diagnosis of Pulmonary Lymphangioleiomyomatosis. Appl Immunohistochem Mol Morphol. 2022;30(2):108-112.

  71. Lovrenski A, Vrekić Ž, Škrbić D, Andrejić Višnjić B, Vasilijević M, Vrtunski More L. An autopsy case of massive pulmonary tumor embolism due to undiagnosed prostatic adenocarcinoma. Forensic Science, Medicine and Pathology 2020; 16: 152-156.

  72. Lovrenski A, Vasilijević M, Panjković M, Tegeltija D, Vučković D, Baroš I, Lovrenski J. Sclerosing Pneumocytoma: A Ten-Year Experience at a Western Balkan University Hospital. Medicina (Kaunas) 2019;55, 27.

  73. Lovrenski J, Vilotijević Dautović G, Lovrenski A. Reduced or absent „lung sliding“ – a novel lung ultrasound sign of pediatric foreign body aspiration. J Ultrasound Med 2019;00:1-4. https://doi.org/10.1002/jum.14988

  74. Lovrenski A, Ilić A, Kuhajda I, Tegeltija D, Lovrenski J. Intrapulmonary solitary fibrous tumor. Srpski Arhiv za celokupno lekarstvo 2020; 148(1-2): 106-10.

  75. Tegeltija D, Lovrenski A, Vasiljević T, Samardžija G, Kuhajda I. Exogenous lipoid pneumonia mimicking multifocal subpleural tumors. Srpski arhiv za celokupno lekarstvo 2020; 148(3-4): 207-210.

  76. Lovrenski J, Zahorjanski S, Strahinić M, Varga I, Lovrenski A, Brestovački-Svitlica B. Ionizing radiation in pediatric radiology: Do medical staff and parent know enough – a regional study in Serbia. Nuclear Technology and Radiation Protection 2019; 34(2): 189-200.

  77. Vasilijević M, Lovrenski A, Panjković M. Tumor budding in tumor tissue among operatively treated patients with lung adenocarcinoma. Vojnosanit Pregl 2021; 78 (4): 409-14.

  78. Tegeltija D, Lovrenski A, Vasiljević T, Andrejić-Višnjić B. Adequacy of biopsy samples for EGFR molecular testing in lung adenocarcinoma. Vojnosanit Pregl 2021; 78 (4): 435-

  79. Andrejić-Višnjić B, Tegeltija D, Lovrenski A, Vučković D, Samardžija G, Tadić Latinović Lj. Mediastinal metastasis of primary extraneural ependymoma: case report. Vojnosanitetski pregled, 2020; 77(11): 1221-6.

  80. Zorić J, Vuković M, Lovrenski A, Samardžija G, Višnjić Andrejić B, Panjković M. Bone and cartilage metaplasia in calcific aortic stenosis. Vojnosanitetski pregled 2021; 78(6): 621-626.

  81. Tegeltija D, Lovrenski A, Vasiljević T, Maksimović S. Association between epidermal growth factor receptor mutation status, clinicopathological characteristics and TTF-1 expression in lung adenocarcinoma – a single center study. Srpski Arhiv za celokupno lekarstvo 2021; 149(3-4): 174-178.

  82. Tegeltija D, Krajnović B, Sekeruš V, Stojanović G, Zarić B, Lovrenski A, Miljković D, Vasiljević T, Maksimović S. Our first experiences with the evaluation of PD-L1 expression. Medical Data 2021; 13(2): 59-64.

  83. Pupavac U, Tegeltija D, Lovrenski A, Sekeruš V, Maksimović S, Bijelović M, Oluški D. Clinical and pathological characteristics of malignant pleural mesothelioma – our five year experience. Medical Data 2019; 11(1): 19-22.

  84. Vrekić Ž, Lovrenski A, Tegeltija D, Ostojić Novković S, Krajnović B, Trudić A. The role of pathohistological and microbiological diagnosis in lung diseases caused by Aspergillus species. Medical Data 2019; 11(2): 93-97.

  85. Samardžija G, Popović M, Lovrenski A, Miljković D, Tegeltija D. Papillary fibroelastoma of the heart – 10 year experience from institute of cardiovascular diseases Sremska Kamenica. Medical Data 2019; 11(2): 87-91.

  86. Byoung Chul Cho, Delvys Rodriguez Abreu, Maen Hussein, Manuel Cobo, Anjan J Patel, Nevena Secen, et al. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Lancet Oncol 2022.

  87. F.Passiglia1, L. Righi1, A. Listi1, F. Tabbò1, P. Bironzo1, M.L. Reale1, C. Sini2, S. Vallone3, F. Arizio4, M.V. Pacchiana Parravicini4, L. Mazilu5, H.Linardou6, E. Roca7, L. Buffoni8, K. Mohorcic9, V. Barbieri10, D. Pignataro11, A. Araújo12, L. Paz-Ares13, E. Felip14, N. Secen15. . The European Program for ROutine testing of Patients with Advanced lung cancer (EPROPA) 1-year activity .2022.

  88. Radosavljevic S, Andrijevic I, Matijasevic J, Obradovic D, Joves B, Krunic S, Sovilj-Gmizic S, Pekovic S, Milutinov-Ilic S, Vukoja M.European Respiratory Journal Sep 2021, 58 (suppl 65) PA1080; DOI: 10.1183/13993003.congress-2021.PA1080

  89. Obradovic D, Esquinas AM. Hyponatremia at discharge: A solid risk or accidental findings in Community-acquired pneumonia.Eur J Intern Med 2020;78:135-136

  90. M26 Karim H.M.R., Obradović D. Esquinas A.M. Preintubation feedback controlled machine delivered noninvasive ventilation versus human delivered traditional mask ventilation: is human performance inferior to machine?.J Clin Monit Comput 2020:34;1131–1132 https://doi.org/10.1007/s10877-019-00394-w

  91. M23 Obradovic D, Joves B, Vujovic I, Vukoja M, Stefanovic S, Gmizic Sovilj S. Is age-adjusted MEWS upon admission a relevant prognostic tool for final outcome? Srp Arh Celok Lek. 2020;148(11-12):701-705│DOI: https://doi.org/10.2298/SARH181008058O

  92. M23 Ivanov I, Veselinov V, Celic D, Dejanovic J, Obradovic D, Knezevic V: Lung ultrasound for volume status assessment in chronic hemodialysis patients. Vojnosanit Pregl 2020; 77(9): 943–949.;, DOI:10.2298/VSP180622167I

  93. M23 Dejanovic Ј, Ivanov I, Popov T, Cankovic M, Vulin A, Obradovic D, Ivanovic V, Stojsic-Milosavljevic A: Clinical characteristic and management of elderly patients with myocardial infarction. Srpski arhiv za celokupno lekarstvo 01/2019;, DOI:10.2298/SARH171016011D

  94. M21a Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, Goossens H; Global-PPS network. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018.

  95. M21 Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Thomas C. Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A,. McDonnell MJ,. Chalmers JD: The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. European Respiratory Journal 2018; 51(2):1701953., DOI:10.1183/13993003.01953-2017

  96. M21 Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ: Characterisation of the “Frequent Exacerbator Phenotype” in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2018; 197(11)., DOI:10.1164/rccm.201711-2202OC

  97. M23 Obradović D, Joveš B, Milić S, Matijašević J, Sovilj-Gmizić S. Deciding on thrombolytic therapy in pulmonary embolism: Is there room for lactate. Srpski arhiv za celokupno lekarstvo 2018;146(7-8):436-439│ DOI: https://doi.org/10.2298/SARH170126157O.

  98. M34 Radosavljevic S, Andrijevic I, Matijasevic J,Obradovic D, Krunic S,Ilić Milutinov S ,Bokan A. Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery. European Respiratory Journal 2020,56(suppl 64)1637;DOI:10.1183/13993003.congress-2020.1637

  99. M34 Joveš B, Obradović D, Matijašević J, Gmizić Sovilj S, Vujović I.Recognizing the high-risk patients with sepsis on time: MEWS, qSOFA or SIRS? European Respiratory Journal 2019;54: PA4008;DOI:10.1183/13993003.congress-2019.PA4008

  100. Vendrell M, Obradović D., Diel R., de Gracia J. Epidemiology. In: Chalmers J., Polverino E., Aliberti S. (eds) Bronchiectasis. Springer;2018: 27-37 , ISBN: 978-3-319-61451-9, DOI:10.1007/978-3-319-61452-6_3

  101. Obradovic D. Respiratory care in non invasive ventilation- postintensive-care step down unit. In : Esquinas AM, Alahmari MD (eds). Respiratory care in Noninvasive Mechanical Ventilatory support: Principles and Practice. Nova Science Pub Inc; 2021:581-587

  102. Obradovic D, Batranovic U. Noninvasive Mechanical Ventilation and Echocardiography. In: Esquinas AM (ed). Teaching pearls in Noninvasive mechanical ventilation: Key practical insights. Springer 2022: 193-202.

  103. Paul Zarogoulidis , Wolfgang Hohenforst-Schmidt2l, Haidong Huang, Jun Zhou, Qin Wang, Xiangqi Wang, Ying Xia, Yinfeng Ding, Chong Bai, Christoforos Kosmidis, Konstantinos Sapalidis, Chrysanthi Sardeli, Kosmas Tsakiridis, Bojan Zaric, Tomi Kovacevic, Vladimir Stojsic, Tatjana Sarcev, Daliborka Bursac, Biljana Kukic, Sofia Baka, Evagelia Athanasiou, Dimitrios Hatzibougias, Electra Michalopoulou-Manoloutsiou, Savvas Petanidis, Dimitris Drougas, Konstantinos Drevelegas, Dimitris Paliouras, Nikolaos Barbetakis, Anastasios Vagionas, Lutz Freitag, Aimilios Lallas, Ioannis Boukovinas, Dimitris Petridis, Aris Ioannidis, Dimitris Matthaios, Konstantinos Romanidis, Chrisanthi Karapantzou. Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G J Cancer 2021.

  104. Paul Zarogoulidis, Haidong Huang, Jun Zhou, Yunye Ning, Meng Yang, Jiannan Wang, Rong Zhang, Chong Bai, Xiaping Shen, Zhiang Huang, Dimitris Petridis, Christoforos Kosmidis, Maria Kosmidou, Kosmas Tsakiridis, Wolfgang Hohenforst-Schmidt, Sofia Baka, Savas Petanidis, Bojan Zaric, Tomi Kovacevic, Vladimir Stojsic, Tatjana Sarcev, Daliborka Bursac, Biljana Kukic, Aggeliki Rapti, Stelian Pantea, Otelia Rogoveanu, Ion Rogoveanu, Konstantinos Romanidis, Issak Kesisoglou, Aris Ioannidis, Anastasios Vagionas, Konstantinos Sapalidis. Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons . Expert Review of Medical Devices 2021;

  105. Paul Zarogoulidis, Vagelis Christakidis, Dimitris Petridis, Konstantinos Sapalidis, Chriforos Kosmidis, Anastasios Vagionas, Eleni-Isidora Perdikouri, Wolfgang Hohenforst-Schmidt, Haidong Huang, Savvas Petanidis, Kosmas Tsakiridis, Sofia Baka, Konstantinos Romanidis, Bojan Zaric, Tomi Kovacevic, Vladimir Stojsic, Tatjana Sarcev, Daliborka Bursac, Biljana Kukic, Ioannis Boukovinas, Christos Tolis, Chrysanthi Sardeli. Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination. Expert Review of Respiratory Medicine 2021.

  106. Paul Zarogoulidis , Dimitris Petridis, Konstantinos Sapalidis, Kosmas Tsakiridis, Sofia Baka, Anastasios Vagionas, Wolfgang Hohenforst-Schmidt, Lutz Freitag, Haidong Huang, Chong Bai, Dimitris Drougas, Vasiliki Theofilatou, Konstantinos Romanidis, Eleni-Isidora Perdikouri, Savas Petanidis, Bojan Zaric, Tomi Kovacevic, Vladimir Stojsic, Tatjana Sarcev, Daliborka Bursac, Biljana Kukic, Branislav Perin, Nikolaos Courcoutsakis, Evagelia Athanasiou, Dimitrios Hatzibougias, Konstantinos Drevelegas, Ioannis Boukovinas, Maria Kosmidou, Christoforos Kosmidis. Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.J Cancer 2020.

  107. Lazic Z, Stankovic I, Milenkovic B, Zvezdin B, Hromis S, Jankovic S, Cupurdija V. Characteristicsof COPD Phenotypes in Serbia. Int J ChronObstructPulmon Dis. 2021;16:643-654. M22

  108. Ilić M, Kopitović I , Vulin A, Zvezdin B, Hromiš S, Kolarov V, Kuhajda D, Vukoja M.Frequencyandeffectsofseasonalflyvaccines on exacerbationsofchronicobstructivepulmonarydisease in Serbia. VojnosanitPregl 2021; 78(2): 179–185M23

  109. Ilić M, Kopitović I, Kuhajda D, Zvezdin B, Lalić N, Hromiš S, Vulin A. The influence of pulmonary rehabilitation on the exacerbations of chronic obstructive pulmonary disease in Serbia. Srp ArhCelokLek. 2020;148(5-6):344-349M23

  110. Vojnović J. Hromiš S. The importance of the interface in the interface in the management of acute respiratory failure. Sestrinskareč. 2020;23(81), 8-11. M52

  111. Jusufović E, Zugic V, Kosnik M, JovančevićDrvenica M, Hromis S, Nurkic J, Al Ahamada, BulatKardumLj, SejdinovićR, Jusufović A. Comparative Efficacy of Long-Acting Muscarinig Antagonist in COPD: Real Life Study. European Respiratory Journal 2020;56: Suppl. 64, 544: DOI:10.1183/13993003.conress-2020.544 M34

  112. Vukoja M, Kopitović I, Lazić Z, Milenković B, Stanković J, Zvezdin B, DudvarskiIlić A, Cekerevac I, Vukčević M, Zugic V, Hromis S, Diagnosis and Management of Chronic Obstructive Pulmonary Diseases in Serbia: an expert group position statement. Int J Chron Pulmon Dis. 2019; 14:1993-2002. M22

  113. Hromiš S, Dugajlić M, Zvezdin B, Kolarov V, Crnobrnja J, JovančevićDrvenica M, Šijačić D. Severe asthma registry from the Institute for pulmonary diseases of Vojvodina: Baseline characteristics. ERJ 2019; 54: Suppl. 63, DOI: 10.1183/13993003.congress-2019.PA2714 M34

  114. Buljcik-Cupic M, Savovic S, Hromis S, Lemajic-Komazec S,Karaba-Jakovljevic D. Incidence ofsensitization to specificinhalatoryallergens in patientssuffering from allergicrhinitis.Vojnosanitetskipregled 2019;76:50-54. M23

  115. Zugic V, Hromis S. Global Initiative for Chronic Obstructive Lung Diseases: can we do better? Egypt J Chest Dis Tuberc2019;68:267-269.M52

  116. Papović J, Vrtunski-More L, Ilić A, Maksimović O, Bogdan M. LEGIONELOZE, LEGIONARSKA BOLEST. MD Medical data 2019; 11: Suplement.

  117. Peković S., Vučićević Trobok J., Bokan A. Pulmonary thromboembolism and acquired thrombophilia in young women. Medicina danas 2019;18(suppl 1):56

  118. Vucicevic Trobok J, Pekovic S, Bokan A, Miric M, Ilic M. BTS recommendations for outpatient treatment of pulmonary embolism. Review Article. Respiratio. 2019;9 (1-2):155-160.

  119. Obradović S, Matijašević J, Jović Z, Batranović U, Marić J, Đenić N, Gavrilović S, sekulić I, Peković S, Rusović S. Trobok J. Angioplastika na plućnim arterijama kod hronične tromboembolijske bolesti pluća. MD-Medical Data, Vol 11/sup-novembar 2019;46-48.

  120. Stanislava Sovilj Gmizić, Biljana Joveš, Dušanka Obradović, Jadranka Vučićević Trobok, Sandra Peković, Aleksandar Bokan. Does hyperlactatemia predict mortality in acute intermediate-risk pulmonaryembolism? Available from: https://www.researchgate.net/publication/334749604_Does_hyperlactatemia_predict_mortality_in_acute_intermediate-risk_pulmonary_embolism

  121. Obradovic S, Dzudovic B, Subotic B, Matijasevic J, Mladenovic Z, Bokan A, Trobok J, Pekovic S, Salinger-Martinovic S, Jovanovic Lj, Kos Lj, Kovacevic-Preradovic T, Nikolic M, Miloradovic V, Kovacevic-Kuzmanovic A, Zec N, Markovic-Nikolic N, Srdanovic I, Gluvic Z, Kafedzic S, Pancevacki S, Neskovic A, Konstantinides S. Predictive value of heart failure with reduced versus preserved ejection fraction for outcome in pulmonary embolism. ESC Heart Fail. 2020;7(6):4061–70. doi: 10.1002/ehf2.13015. Epub ahead of print. PMID: 32936530; PMCID: PMC

  122. Matijašević J, Miric M, Vucicevic-Trobok J, Pekovic S, Andrijevic I, Dzudovic B, Subotic B, Obradovic S. Sex-specific differences and risk factors for 30-day mortality in acute pulmonary embolism – results from the Serbian university multicenter pulmonary embolism registry. Vojnosanitetski pregled. 2021. OnLine- First Issue 00, Pages: 48-48. https://doi.org/10.2298/vsp200830048

  123. Radosavljevic S, Andrijevic I, Matijasevic J, Obradovic D, Joves B, Krunic S, Sovilj Gmizic S, Pekovic S, Milutinov Ilic S, Vukoja M. Noninvasive ventilatory support in patients with COVID-19 pneumonia in high dependency unit: a single center study, September 2021, DOI: 10.1183/13993003.congress-2021.PA1080, Conference: ERS International Congress 2021 abstracts

  124. Vucicevic Trobok J, Pekovic S, Bokan A, Benic M. Plućna endarterektomija kao zlatni standard za lečenje hronične tromboembolijske plućne hipertenzije – prikaz slučaja. Majski pulmološki dani. Respiratio. 2022;

  125. Đolai M, Ilić Sabo J, Trivunić Dajko S, Lakić T, Krajnović B, Vrekić Ž. Multicystic 4 dysplastic kidney.MD-Medical Data.2018;10(3):159-61. M52

  126. Aleksić N, Ilić Sabo J, Andrejić Višnjić B, Čapo I, Krajnović B, Rakočević N. Demografske karakteristike, histološki tipovi i komplikacije apendicitisa operisanih u Kliničkom centru Vojvodine u toku jedne kalendarske godine. MD-Medical Data. 2020;12(3):155-9. М52

  127. Vrekić Ž, Lovrenski A, Tegeltija D, Novković Ostojić S, Krajnović B, Považan A. MD-Medical Data 2019;11(2): 093-097. (M52)

  128. Tegeltija D,Krajnović B, Sekeruš V, Stojanović G, Zarić B, Lovrenski A, Miljković D,Vasiljevićć T, Maksimović S. NAŠA PRVA ISKUSTVA U EVALUACIJI PD-L1 EKSPRESIJE. MD-Medical Data 2021;13(2): 059-064 .(M52)

  129. B. Krajnovic, N. Gardic, D. Tegeltija, V. Sekerus, D. Miljkovic, A. LovrenskiComparison of transthoracic fine needle aspiration cytology and surgical biopsy in patients with peripheral pulmonary lesions ( Meeting abstract).Virchows archiv, (2021), Vol 479 br.,str S173-S173.

  130. Škrbic D, Trudić A, Đurić M, Kurucin T, Hromiš S, Handnadjev M, Tušek B, Považan Đ. Antimicrobial susceptibility of bacteria isolated from adult patients with cystic fibrosis treated in the Institute for Pulmonary Disease of Vojvodina Sremska Kamenica, Serbia, 1 st Adult Cystic Fibrosis International Workshop, Milano, Italy.European Respiratory Pulmonary Diseases 2019; Vol 5; issue 1; Suppl2. Abstract Book:13. pp13-14. M34-0,5

  131. Prodanović Simeunović J, Manojlović M, Milankov A, Pejaković S, Stepanović K, Slankamenac S, Benc D, Vuković B, Tušek B, Škrbić D, Đurić M. Šećerna bolest u cističnoj fibrozi.11 Srpski kongres o šećernoj bolesti sa internacionalnim učešćem. Beograd, 24-27.novembar 2019, Zbornik sažetaka: 30. M64-0,2

  132. Tušek B, Đurić M, Hromiš S, Škrbić D, Šijačić D. Cistična fibroza dijagnostkovana u adultnoj dobi - prikaz slučaja. Cystic fibrosis diagnosed in adulthood. A case report. 6th Congress of Serbian respiratory medicine with international participation. 15-17.11.2019. Kopaonik . MD Medical Data. Medicinska revija. 2019; Vol 11(Suplement):145-146. M64-0,2

  133. Skrbic D. The management of acute exacerbation of bronchiectasis. Abstract book of Fourth Congress of the pneumophtisiologists of Republic North Macedonia with international participation 12-14.09.2019. Struga, North Macedonia. Makedonski medicinski pregled. God. 73 (supl. 104), стр.15-16.

  134. Tušek B, Đurić M, Škrbić D, Šijačić D, Bjelajac D. Chilaiditi-jev sindrom – Prikaz slučaja. Chilaiditi syndrome – Case report. MD - Medical Data 2019; 11(3-4): 163-165. UDK 616.34-008-079.4

  135. Lovrenski A, Vrekic Z, Skrbic D, Andrejic-Visnjic B, Vasilijevic M, Vrtunski-More L. An autopsy case of massive pulmonary tumor embolism due to undiagnosed prostatic adenocarcinoma. Forensic Science, Medicine and Pathology. Volume 16, pages 152–156 (2020)

  136. Bursać D, Zarić B, Kovačević T, Stojšić V, Vagionas A, Boukovinas I, Tsakiridis K, Kosmidis C, Sapalidis K, Romanidis K, Courcoutsakis N, Matthaios D, Zarogoulidis P, Sardeli C, Sekeruš V. Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series. Case Rep Oncol. 2021;14(2):716-724.

  137. Stojčević Maletić J, Bačulov K, Sekeruš V, Vučinić N, Milanović B, Barjaktarović I. Detection of alpha-1 antitrypsin gene mutations by polymerase chain reaction in patients with chronic obstructive pulmonary disease. Med Pregl. 2019;LXXII (5-6):148-53.

  138. Tegeltija D, Krajnović B, Sekeruš V, Stojanović G, Zarić B, Lovrenski A, Miljković D, Vasiljević T, Maksimović T. Our first experiences with the evaluation of PD-L1 expression. MD-Medical Data 2021;13(2):059-064.

  139. Pupavac U, Tegeltija D, Lovrenski A, Sekeruš V, Maksimović S, Bijelović M, Oluški D. Clinical and pathological characteristics of malignant pleural mesothelioma – our five year experience. MD-Medical Data. 2019;11(1):019-22.

  140. Tegeltija D, Lovrenski A, Vasiljević T, Sekeruš V, Maksimović S, Kuhajda I, et al. Da li je histološka građa adenocarcinoma pluća u dijagnostičkim i terapijskim uzorcima identična? Respiratio. 2019;9(1-2):30-5.

  141. Bursać D, Šarčev T, Sazdanić Velikić D, Đukić N, Sekeruš V, Petkov S, Stojanović G. Patient with Primary T790M Mutation in Lung Adenocarcinoma Treated with Gefitinib as a First-Line and Osimertinib as a Second-Line Therapy: A Case Report. J Carcinog Mutagen 2019;10:3.

  142. Sekeruš V, Vujasin D, Tegeltija D, Lovrenski A, Andrijević I. The application of liquid biopsy in molecular diagnostics of lung cancer. Clin Chem Lab Med 2021; 59, Special Suppl, pp S94 – S998. EuroMedLab, Munich, 2021.

  143. Krajnović B, Sekeruš V, Tegeltija D, Lovrenski A, Vučković D, Miljković D, Vujasin D. Liquid biopsy and lung cancer. Virchows Archiv. Vol. 479, No. 1, Str. 137-137.European Congress of Pathology, Gothenburg, 2021.

  144. Krajnović B, Sekeruš V, Stojanović G, Zarić B, Lazin S, Lovrenski A, Maksimović S, Tegeltija D. PD-L1 expression in NSCLC - our institution experience. Virchows Archiv. Vol. 479, No. 1, Str. 161-161. European Congress of Pathology, Gothenburg, 2021.

  145. Krajnović B, Gardić N, Tegeltija D, Sekeruš V, Miljković D, Lovrenski A. Comparison of transthoracic fine needle aspiration cytology and surgical biopsy in patients with peripheral pulmonary lesions. Virchows Archiv. Vol. 479, No. 1, Str. 161-161. European Congress of Pathology, Gothenburg, 2021.

  146. Sekeruš V, Stojanović G, Bursać D, Tegeltija D, Stolić M, Andrijević I. Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790M mutation testing. Clinica Chimica Acta. 2019;493S1:S563-83,W286.EuroMedLab, Barcelona, 2019.

  147. Stanimirov B, Stankov K, Dević M, Pavlović N, Đanić M, Sekeruš V, Mikov M. Ursodeoxycholic acid influences antioxidative capacity in human breast adenocarcinoma cell line through Nrf2-dependent axis. Serbian Association for Cancer Research (SDIR); Str. 59-59. Congress of the Serbian Association for Cancer Research – SDIR with international participation, Beograd, 2021.

  148. Sekeruš V, Stankov K, Kojić V, Mikov M. Influence of bile acids on the pro-apoptotic effect of the DNA methyltransferase inhibitor in human colon adenocarcinoma cells. Str. 188-189. Kongres farmakologa Srbije, Novi Sad, 2019.

  149. Lovrenski Aleksandra, Tegeltija D, Miljković D, Sekeruš V, Stojšić V, Zarić B. Anaplastic Lymphoma Kinase testing with immunohistochemistry in patients with advanced non-small celllung cancer. Vol. 11, No. 3, Str. 118-119. Kongres respiratorne medicine Srbije sa međunarodnim učešćem, Kopaonik, 2019.

  150. Tegeltija D, Lovrenski A, Sekeruš V, Maksimović S, Kuhajda I, Popović M. EGFR MUTACIJE – NAŠE ISKUSTVO. Kongres respiratorne medicine Srbije sa međunarodnim učešćem, Kopaonik, 2019.

  151. Kuhajda I, Kašiković-Lečić S, Ergelašev I, Kuhajda D, Đokić J. COVID-19 pneumonia complicated by late presentation of bilateral spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema. Srp Arh Celok Lek. 2021.

  152. Kuhajda D, Kuhajda I, Maksimovic S, Crnobrnja J, Lalic N, Bojovic M. Risk factors as outcome predictors of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Srp Arh Celok Lek. 2022, vol 150 (1-2); 35-40

  153. Lalić N, Tegeltija D, Kuhajda I, Tomić S, Lalić I. Metastatic atypical lung carcinoid treated with combined therapies Srp Arh Celok Lek. 2019.

  154. Lovrenski A, Ilić A, Kuhajda I, Tegeltija D, Lovrenski J. Intrapulmonary solitary fibrous tumor Srp Arh Celok Lek. 2019.

  155. Alvarez-Romero C, Martinez-Garcia A, Ternero-Vega J, Diaz-Jimenez P, Jimenez-de-Juan C, Nieto-Martin MD, Roman-Villaran E, Kovacevic T, Bokan D, Hromis S, Djekic-Malbasa J, Beslac S, Zaric B, Gencturk M, Sinaci A, Ollero-Baturone M, Parra-Calderon CL. Predicting 30-days Readmission Risk for COPD Patients Care through a Federated Machine Learning Architecture on FAIR Data: Development and Validation StudyIn. JMIR Medical Informatics, volume 1, April, 2022.

  156. Čamprag Sabo N, Javorac J, Živanović D, Hilčenko S. Pollution by pollen as suspended particles. In: Celec R, ed. Studies of environmental issues through the prism of integration into the wider environment. Hamburg: Verlag Dr. Kovač; 2022. pp. 7-18. (M14)

  157. Živanović D, Mijatović Jovin V, Javorac J, Kvrgić S, Rašković A, Stojkov S, Kašiković Lečić S, Savić N, Kralj M, Milenković A. Measuring pharmacovigilance knowledge and attitudes among healthcare sciences students: development and validation of a universal questionnaire. Eur Rev Med Pharmacol Sci. 2022;26(4):1196-214. (M22) https://doi.org/10.26355/eurrev_202202_28112

  158. Javorac J, Živanović D, Stojkov S, Miličić JĐ, Fradelos E, Savić N. COVID-19 associated pulmonary embolism with D-dimer values within the referent range: a case report and review of the literature. Eur Rev Med Pharmacol Sci. 2021;25(24):7971-5. (M22) https://doi.org/10.26355/eurrev_202112_27647

  159. Živanović D, Jovin VM, Javorac J, Ilić M, Zelić P. Commentary: Registered adverse events following Covid-19 immunization in Serbia. Eur Rev Med Pharmacol Sci. (M22) 2021;25(20):6408-10. https://doi.org/10.26355/eurrev_202110_27014

  160. Javorac J, Jevtić M, Živanović D, Ilić M, Bijelović S, Dragić N. What Are the Effects of Meteorological Factors on Exacerbations of Chronic Obstructive Pulmonary Disease? Atmosphere. 2021;12:442. (M22) https://doi.org/10.3390/atmos12040442

  161. Živanović D, Javorac J, Stojkov S, Jevtić M, Knežević J, Blanuša J, Štimac Grbić D, Paut Kusturica M, Jovanović Lješković N, Todorović N. The COVID-19 pandemic-related psychological distress and job burnout among Serbian pharmacy practitioners: a cross-sectional online study. Eur Rev Med Pharmacol Sci. 2022;26:2639-45. (M22) https://doi.org/10.26355/eurrev_202204_28502m

  162. Fradelos EC, Alikari V, Balta K, Živanović D, Javorac J, Papagiannis D, Tzavella F, Tsaras K, Papathanasiou IV, Zyga S. The effect of spirituality on illness perceptions in patients undergoing hemodialysis. Adv Exp Med Biol. 2021;1337:65-75. (M23) https://doi.org/10.1007/978-3-030-78771-4_8

  163. Živanović D, Javorac J, Friganović A, Fradelos E. The docimologically based evaluation of knowledge in the vocational education of healthcare professionals. Croat J Educ. 2020;22(4):1113-35. (M23) https://doi.org/10.15516/cje.v22i4.3806

  164. Živanović D, Mijatović Jovin V, Javorac J, Samojlik I, Rašković A, Jevtić M, Stojkov S, Jovanović Lješković N, Perković Vukčević N. Pharmacovigilance in Serbia: a ten-year pharmacoepidemiological analysis. Acta Clin Croat. (Accepted) (M23)

  165. Milenković A, Ilić M, Javorac J, Savić N, Lalić N. Lymphangioleiomyomatosis and Langerhans cell histiocytosis - two case reports from our practice. Srp Arh Celok Lek. Online First March, 29 2022. (M23) https://doi.org/10.2298/SARH211203034M

  166. Kašiković Lečić S, Lovrenski A, Đokić J, Popović M, Javorac J, Milenković A, Živanović D. Does miliary sarcoidosis really exist? A case report and review of the literature. Eur Rev Med Pharmacol Sci. Forthcoming 2022. (M22)

  167. Javorac J, Živanović D, Lovrenski A, Milenković A, Kukavica D, Ilić M. Laryngeal tuberculosis – a neglected disease that can mimic laryngeal carcinoma. International Journal of Health Services Research and Policy. 2021;6(1):144-150. (M52) https://doi.org/10.33457/ijhsrp.869470

  168. Milenković A, Javorac J, Ilić M, Kukavica D. Tuberkuloza dojke – prikaz slučaja. MD – Medical Data. 2021;13(1):231-3. (M52) UDK: 618.19-002.5

  169. Živanović D, Javorac J, Stojkov S, Čamprag Szabo N. Public health issues of global population ageing. Black Sea Journal of Health Science. 2020;3(3):88-93. (M52)

  170. Živanović D, Javorac J, Brestovački Svitlica B, Stojkov S. Job satisfaction as an objective indicator of work motivation among intensive care nurses. International Journal of Health Services Research and Policy. 2019;4(2):84-94. (M52) https://doi.org/10.23884/ijhsrp.2019.4.2.02

  171. Javorac J, Živanović D, Ilić M, Milenković A. Multisistemska histiocitoza Langerhansovih ćelija sa dominantnim lezijama u plućnom parenhimu. Sestrinska reč. 2020;24(80):26-8. (M52)

  172. Živanović D, Javorac J, Dimoski Z, Šumonja S. Nursing profession in the contemporary healthcare system and public health: new roles and challenges. Health Care. 2021;50(2):74-86. (M53)https://doi.org/10.5937/zdravzast50-30873

  173. Javorac J, Jevtić M, Živanović D, Ilić M. Uticaj aerozagađenja na egzacerbacije hronične opstruktivne bolesti pluća. Zdravstvena zaštita. 2021;50(1):67-78. (M53) https://doi.org/10.5937/zdravzast50-30791

  174. Živanović DB,Javorac JM, Knežević JD. Burnout syndrome among critical care nurses. Hospital Pharmacology. 2019;6(3):848-56. (M53) https://doi.org/10.5937/hpimj1903848Z

  175. Živanović D, Javorac J, Javorac T, Kralj M. Implementation of artificial neural networks and neurocomputers in medicine: from fantastic idea to intelligent screening systems. Zdravstvena zaštita. 2019;48(4):43-50. (M53) https://doi.org/10.5937/ZZ1904043Z

  176. Živanović D, Javorac J. The appropriate use of the Vancouver referencing style in scientific papers published in biomedical journals. Zdravstvena zaštita. 2019;48(3):43-8. (M53)https://doi.org/10.5937/ZZ1903043Z

  177. Javorac JM, Janjić GG, Živanović DB, Javorac TM, Marković AR. The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders. Hospital Pharmacology. 2019;6(1):765-73. (M53)https://doi.org/10.5937/hpimj1901765J

  178. Živanović D, Javorac J, Filipović B, Doronjski A, Milenković A, Dimoski Z, Smuđa M. Etičke dileme u medicinskom tretmanu novorođenčadi sa teškim kongenitalnim malformacijama: zaostavština bebe Doe. Sestrinska vizija. 2021;5(2):22-7. (M54)

  179. Javorac J, Živanović D, Milenković A. COVID-19 pneumonija: značaj drugih dijagnostičkih pristupa osim PCR testiranja – prikaz slučaja. Sestrinska vizija. 2020;4(2):25-8. (M54)

  180. Stojkov S, Đuranović Miličić J,Živanović D, Jovanović Lješković N, Javorac J. Implementation of information technologies in the healthcare system od Serbia – patients’ attitudes about e-prescription (in Serbian). In: Proceeding book of X International Conference on Social and Technological Development “STED 2021”; 2021 Jun 03-06; Trebinje, Republic of Srpska, Bosnia & Herzegovina. Banja Luka: PIM University; 2021. pp. 722-8. (M33)

  181. Đuranović Miličić J, Stojkov S,Živanović D, Javorac J, Đuranović S, Stjepanović I. Effects of mass media in the COVID-19 pandemic on health promotion (in Serbian). In: Proceeding book ofXInternational Conference on Social and Technological Development “STED 2021”; 2021 Jun 03-06; Trebinje, Republic of Srpska, Bosnia & Herzegovina. Banja Luka: PIM University; 2021. pp. 729-42. (M33)

  182. Javorac J, Živanović D, Lovrenski A, Kukavica D, Milenković A, Ilić M. Laryngeal tuberculosis misdiagnosed as laryngeal carcinoma – a case report.In: Proceeding book of 4th International Health Sciences Conference “IHSC 2020”; 2020 Nov 05-06; Diyarbakir, Turkey. Diyarbakir: Dicle University; 2020. pp. 365-8. (M33)

  183. Živanović D, Javorac J, Šumonja S, Đuranović Miličić J, Smuđa M. Pharmacovigilance: an essential activity in the post-marketing phase of drug effects monitoring (In Serbian). In: Thematic Collected Papers from the 12th International Interdisciplinary Scientific Conference “HORIZONS 2021”; 2021 May 14-15; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2021. pp. 166-74. (M33)

  184. Đuranović Miličić J, Stojkov S, Živanović D, Javorac J. How to preserve reproductive health in a pandemic? (In Serbian). In: Thematic Collected Papers from the 12th International Interdisciplinary Scientific Conference “HORIZONS 2021”; 2021 May 14-15; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2021. pp. 84-91. (M33)

  185. Javorac J, Javorac T, Živanović D, Stojkov S, Čamprag Sabo N. The attitudes of medical students towards milk and dairy products in the nutrition (In Serbian). In: Thematic Collected Papers from the 12th International Interdisciplinary Scientific Conference “HORIZONS 2021”; 2021 May 14-15; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2021. pp. 101-8. (M33)

  186. Čamprag Sabo N, Stojkov S, Živanović D, Javorac J. Protein supplementation in athletes (In Serbian). In: Thematic Collected Papers from the 12th International Interdisciplinary Scientific Conference “HORIZONS 2021”; 2021 May 14-15; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2021. pp. 69-76. (M33)

  187. Javorac J,Živanović D, Sokolova L. Epidemiological characteristics of lung carcinoma. In: Thematic Collected Papers from the 11th International Interdisciplinary Scientific Conference “HORIZONS 2020”; 2020 May 15-16; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2020. pp. 189-95. (M33)

  188. Živanović D,Javorac J, Milutinović N. WASH program: global public health issues and possibilities of implementation at local level (In Serbian). In: Thematic Collected Papers from the 11th International Interdisciplinary Scientific Conference “HORIZONS 2020”; 2020 May 15-16; Subotica, Serbia. Subotica: College of Vocational Studies of Preschool Teachers and Sports Trainers; 2020. pp. 218-24. (M33)

  189. Ilić M, Savić N, Lalić N, Veres K, Javorac J, Kopitovic I. How the COVID19 pandemic changed the attitude versus seasonal flu vaccination among COPD patients in Serbia? Eur Resp J. 2021;58(65):PA928. (M34) https://doi.org/10.1183/13993003.congress-2021.PA928

  190. Javorac J, Zivanovic D, Ilic M, Kopitovic I, Milenkovic A, Savic N. Tracheobronchopathia osteochondroplastica: a study of 22 patients from Serbia (abstract). In: Proceeding book of the 132nd Congress of the Korean Academy of Tuberculosis and Respiratory Diseases “KATRD International Conference 2021”; 2021 Nov 11-12; Seoul, Korea. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases; 2021. p. 551. (M34)

  191. Zivanovic D, Javorac J, Blanusa J, Stojkov S, Knezevic J, Kopitovic I, Ilic M. The COVID-19 pandemic - related burnout and distress among healthcare professionals treating patients with respiratory diseases in Serbia (abstract). In: Proceeding book of the 132nd Congress of the Korean Academy of Tuberculosis and Respiratory Diseases “KATRD International Conference 2021”; 2021 Nov 11-12; Seoul, Korea. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases; 2021. pp. 588-9. (M34)

  192. Ilic M, Kopitovic I, Javorac J, Kukavica D, Savic N, Vukosav D, Lalic N. Will there be a permanent problem with Tuberculosis in future due to the second category of patients in Serbia (abstract). In: Proceeding book of the 132nd Congress of the Korean Academy of Tuberculosis and Respiratory Diseases “KATRD International Conference 2021”; 2021 Nov 11-12; Seoul, Korea. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases; 2021. p. 348. (M34)

  193. Živanović D, Mijatović Jovin V, Javorac J, Samojlik I. The public health issues of Adverse Drug Reaction (ADR) monitoring: a review (abstract). In: Proceeding book of 4th International Health Sciences Conference “IHSC 2020”; 2020 Nov 05-06; Diyarbakir, Turkey. Diyarbakir: Dicle University; 2020. pp. 12-3. (M34)

  194. Živanović D,Javorac J, Kvrgić S. Theoretical aspects of the Quality of Life assessment in patients undergoing hemodialysis (abstract). In: Proceeding book of 4th International Health Sciences Conference “IHSC 2020”; 2020 Nov 05-06; Diyarbakir, Turkey. Diyarbakir: Dicle University; 2020. pp. 10-1. (M34)

  195. Javorac J, Živanović D, Jevtić M, Ilić M. COPD and climate change: what the future holds? (abstract). In: Proceeding book of 4th International Health Sciences Conference “IHSC 2020”; 2020 Nov 05-06; Diyarbakir, Turkey. Diyarbakir: Dicle University; 2020. pp. 4-5. (M34)

  196. Živanović D, Matijašević J, Stojkov S, Javorac J. The incidence of burnout among critical care nurses: a short cross-sectional study (abstract). In: Proceedings of 2nd International Congress of Hygiene and Preventive Medicine; 2019 April 10-13; Novi Sad, Serbia; Novi Sad: Faculty of Medicine; 2019. p. 55. (M34)

  197. Anđelković J, Javorac J, Živanović D, Stojkov S, Smuđa M, Ćućuz V. Dijagnostičko-prognostički značaj vrednosti D-dimera kod COVID-19 pacijenata (abstract in Serbian). In: Zbornik sažetaka Simpozijuma "COVID-19 infekcija - dijagnostički i prognostički biohemijski parametri"; 2022 Mar 18; Belgrade, Serbia; Belgrade: Udruženje farmaceuta Beograd; 2022. p. 21. (M64)

  198. Anđelković J, Atanacković M, Živanović D, Javorac J, Ćućuz V, Stojkov S. Rani odgovor farmaceuta na COVID-19 pandemiju: intenziviranje javnozdravstvenih usluga u apotekama u Srbiji (abstract in Serbian). In: Zbornik sažetaka Simpozijuma "COVID-19 infekcija - dijagnostički i prognostički biohemijski parametri"; 2022 Mar 18; Belgrade, Serbia; Belgrade: Udruženje farmaceuta Beograd; 2022. p. 17. (M64)

  199. Živanović DB, Mijatović Jovin VM, Javorac JM, Samojlik IN, Javorac TM. Procena bazičnog znanja studenata Medicinskog fakulteta u Novom Sadu, Srbija o prijavljivanju neželjenih reakcija na lekove (NRL): studija preseka (abstract in Serbian). In: Zbornik sažetaka XII Nedelje bolničke kliničke farmakologije; 2020 Nov 28-29; Belgrade, Serbia. Belgrade: Srpsko lekarsko društvo/Serbian Medical Society; 2020. p. 79. (M64)

  200. Živanović D, Blanuša J, Knežević J, Stojkov S, Javorac J. Prediktori izgaranja kod zdravstvenih radnika tokom pandemije COVID-19 (abstract in Serbian). In: Zbornik radova 68. Kongresa psihologa “Psihologija iz dana u dan”; 2020 Nov 27-28; Belgrade, Serbia. Belgrade: Društvo psihologa Srbije/Serbian Psychological Society; 2020. pp. 64-5. (M64)

  201. Javorac J, Pavlović Popović Z, Dragišić D, Vukosav D, Savić N, Đekić D, Živanović D. Lung manifestations of Langerhans cell histiocytosis (LCH): case report (abstract). In: Proceedings of 6th Congress of Serbian Respiratory Medicine with international participation; 2019 Nov 15-17; Kopaonik, Serbia. MD Medical data. 2019;11(Suppl. Nov):106-7. (M64)

  202. Savić N, Marković Z, Eri Ž, Koledin B, Đekić D, Javorac J. Primary pulmonary botryomycosis: case report (abstract). In: Proceedings of 6th Congress of Serbian Respiratory Medicine with international participation; 2019 Nov 15-17; Kopaonik, Serbia. MD Medical data. 2019;11(Suppl. Nov):128-9. (M64)

  203. Javorac J. Postporođajni psihijatrijski poremećaji (abstract). In: Zbornik radova III Kongresa babica Republike Srbije sa međunarodnim učešćem; 2019 May 24-25; Beograd, Srbija; Beograd: Udruženje zdravstvenih radnika i saradnika TIM “KME”; 2019. p. 32. (M64)

  204. Kuhajda D, Kuhajda I, Maksimovic S, Crnobrnja J, Lalic N, Bojovic M. Risk factors as outcome predictors of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. SrpArhCelokLek. 2022, vol 150 (1-2); 35-40

  205. Kuhajda I, Kašiković-Lečić S, Ergelašev I, Kuhajda D, Đokić J. COVID-19 pneumonia complicated by late presentaqtion of bilateral spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema. SrpArhCelokLek. 2021,DOI: https://doi.org/10.2298/SARH210219033K

  206. Ilic M, Kopitovic I, Vulin A, Zvezdin B, Hromis S, Kolarov V, Kuhajda D, Vukoje M. Frequency and affects of seasonal flu vaccines on exacerbations of chronic obstructive pulmonary disease in Serbia. VojnosanitestskiPregled. 2021, vol 78 (2); 179-185

  207. Ilic M, Kopitovic I, Kuhajda D, Zvezdin B, Lalic N, Hromic S, Vulin A. The influence of pulmonary rehabilitation on exacerbations of chronic obstructive pulmonary disease in Serbia. SrpArhCelokLek. 2020, vol 148 (5-6); 344-349

  208. Strikovic V, Krasnik R, Zvekic-Svorcan J, Demesi-Drljan C, Kuhajda D, Ivanic J, Vuklis D. Potential risk factors for back pain in children. J Back MusculoskelReh. 2019, vol 32 (5); 749-754

  209. Kovacevic P, Matijasevic J, Dragic S, Zlojutro B, Gavrilovic S, Jandric M, Čarapić V et al. Characteristics and outcomes of critically ill patients with influenza A (H1N1) in the western Balkans during the 2019 post-pandemic season [Internet]. Indian Journal of Medical Microbiology. Elsevier; 2021.

  210. Tušek B, Đurić M, Škrbić D, Šijačić D, Bjelajac D. Chilaiditi-jev sindrom -Prikaz slučaja. Chilaiditi syndrome -Case report. MD-Medical Data 2019; 11(3-4):169-171.

  211. Tušek I, Ilić PM, Tušek J, Ivić S, Tušek B. Pediatric mandibular fracture therapy -a case report. Vojnosanit Pregl 2020; 77(6): 647–650. UDC: 616.716.4–001.5-053.2

  212. Tušek I, O'Rourke B, Lekić C, Tušek J, Tušek B. Early childhood caries in multilingual community. Cent Eur J Public Health 2020; 28(4):286-91.

  213. Kolarov V, Kotur Stevuljević J, Ilić M, Bogdan M, Tušek B, Agic A, Dugajlić M, Tot Vereš K, Kutlešić Stević S, Zvezdin B. Factorial analysis of N-acetylcysteine and propolis treatment effects on symptoms, life quality and exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD): a randomized, double-blind, placebo-controlled trial. Eur Rev Med Pharmacol Sci 2022; 26(9): 3192-3199. DOI: 10.26355/eurrev_202205_28737

FaLang translation system by Faboba
Пут доктора Голдмана 4
21204 Сремска Каменица
Србија

Телефон: +381 (0)21 480 5100
Фаx: +381 (0)21 527 960
Позивни центар: 066 880 5312
Именик лекара (xlsx)
Електронска пошта: ipbvojvodine@gmail.com
Интернет адреса: www.institut.rs

ПИБ: 100804605
МБР: 08042462
ЈБКЈС: 02567